Hepatic Venous Pressure Gradient: Measurement and Pitfalls
- PMID: 38945633
- DOI: 10.1016/j.cld.2024.03.009
Hepatic Venous Pressure Gradient: Measurement and Pitfalls
Abstract
Measurement of hepatic venous pressure gradient (HVPG) effectively mirrors the severity of portal hypertension (PH) and offers valuable insights into prognosis of liver disease, including the risk of decompensation and mortality. Additionally, HVPG offers crucial information about treatment response to nonselective beta-blockers and other medications, with its utility demonstrated in clinical trials in patients with PH. Despite the widespread dissemination and validation of noninvasive tests, HVPG still holds a significant role in hepatology. Physicians treating patients with liver diseases should comprehend the HVPG measurement procedure, its applications, and how to interpret the results and potential pitfalls.
Keywords: Beta-blockers invasive; Catheterization; Cirrhosis; HVPG; Portal hypertension; Portal pressure monitoring.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure S.G. Rodrigues, M.G. Delgado, and G. Stirnimann have nothing to disclose. A. Berzigotti is a consultant for Boehringer-Ingelheim. J. Bosch is a consultant for AstraZeneca, Boehringer-Ingelheim, NovoNordisk, Resolution Therapeutics.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources